November 15, 2013

The management team of Tops Friendly Markets has purchased the chain from the private equity firm that owned it, according to published reports.

November 7, 2013

According to a Credit Suisse analysis of the drug channel published Wednesday, drug stores are in for a challenging winter across the front-end with an embattled consumer continuing to hold back and the continued proliferation of dollar stores that are attracting value-driven trips to their channel.

July 22, 2013

Front-end drug store sales are weakening, Credit Suisse reported in a research note.

April 8, 2013

Blackhawk Network Holdings announced its intent to open its initial public offering of 10 million shares at an estimated offering price of $20 to $22 per share.

March 20, 2013

Generic drug maker Sagent Pharmaceuticals has appointed James Hussey as its president, the company said.

February 15, 2013

The Vitamin Shoppe announced that it has closed on the previously announced purchase of Super Supplements — a specialty retailer of vitamins, minerals and supplements — for approximately $50 million.

December 12, 2012

Markwins announced on Wednesday that it has acquired all of the outstanding securities of Physicians Formula for $75 million or $4.90 per share in cash.

September 11, 2012

Walgreens on Monday announced that it has priced an underwritten public offering of senior notes.

March 14, 2012

Grocer A&P has emerged from bankruptcy as a privately held company.

January 3, 2012

Retailers will report weak December front-end sales growth across the drug channel as continued inflation likely was offset by the slow start to the flu season and disappointing overall traffic and volume growth, Credit Suisse research analyst Ed Kelly suggested in a note published Tuesday.

August 30, 2011

Jonathon Singer has been appointed CFO of Sagent Pharmaceuticals, the generic drug maker said.

April 1, 2011

GNC Thursday evening announced its initial public offering of 22.5 million shares of its Class A common stock at an opening price of $16 per share.

March 21, 2011

Following the recent sale of Walgreens' pharmacy benefit management business, Credit Suisse analysts said they are interested in the executive team's updated thinking on their healthcare strategy and plans for the $550 million in proceeds.

October 5, 2010

Generic drug maker Sagent Pharmaceuticals has launched two injectable antibiotics, the company said Tuesday....

May 9, 2010

Actavis and Sagent Pharmaceuticals have agreed to develop and market a group of injectable drugs...